Keyphrases
Catenin
100%
Liver Cancer Stem Cells
100%
Stem Cell Expansion
100%
SHP2
100%
Chemotherapy Response
100%
Liver
66%
Hepatoma Cells
33%
Self-renewal
25%
Dedifferentiation
16%
Cell Division Cycle
16%
Blockage
8%
Hepatoblastoma
8%
Cell-to-cell
8%
Control Cell
8%
Hepatocellular Carcinoma
8%
High-level Expression
8%
Patient Response
8%
Hepatocellular Carcinoma Cells
8%
Hepatocellular Carcinoma Patients
8%
Nuclear Translocation
8%
Chemoresistant
8%
Hepatocellular Carcinoma Therapy
8%
Sorafenib Treatment
8%
Hepatology
8%
Cluster of Differentiation
8%
Transcatheter Arterial Chemoembolization
8%
Glycogen Synthase Kinase
8%
Recurrent Hepatocellular Carcinoma
8%
Epithelial Cell Adhesion
8%
Cell Dedifferentiation
8%
Medicine and Dentistry
Cancer Stem Cell
100%
Liver Cancer
100%
Catenin
100%
Stem Cell Expansion
100%
Hepatocellular Carcinoma
75%
Hepatoma Cell
50%
Cell Dedifferentiation
37%
Cell Cycle
25%
Sorafenib
12%
Carcinoma Cell
12%
Epithelial Cell
12%
Cytosol
12%
Tumor Spheroid
12%
Transcatheter Arterial Chemoembolization
12%
Hepatology
12%
Glycogen Synthase Kinase
12%
Cell Adhesion
12%
Biochemistry, Genetics and Molecular Biology
Stem Cell Expansion
100%
Catenin
100%
Cancer Stem Cell
100%
Cell Dedifferentiation
37%
Cell Cycle
25%
Cell Adhesion
12%
Cluster of Differentiation
12%
Tumor Spheroid
12%
Glycogen Synthase Kinase
12%
Sorafenib
12%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cell Carcinoma
100%
Liver Cancer
100%
Catenin
100%
Sorafenib
10%
Glycogen Synthase Kinase
10%